Ads
related to: medicine
Search results
EU regulator scraps approval for pregnancy drug over cancer risk
Reuters· 7 hours agoThe European Medicines Agency (EMA) on Friday recommended scrapping approval for a drug used to...
Gut bacteria enhance cancer immunotherapy in mouse study
Medical Xpress· 49 minutes agoNow, researchers at Washington University School of Medicine in St. Louis have found, in mice, that...
Nuclear medicine booms in central Indiana - Indianapolis Business Journal
Indianapolis Business Journal· 12 hours agoInside a large manufacturing building on the northwest side, officials at Cardinal Health are busy...
Opinion: I asked several people well past retirement age why they keep working. Here’s what they...
CNN via Yahoo News· 6 hours agoIt’s no exaggeration to say that Dr. Howard Tucker has worked inmedicine for a lifetime. The average...
SLU School of Medicine honors future doctor from Jennings for community work
KSDK St. Louis· 10 hours agoThe Saint Louis University School of Medicine honored one of its soon-to-be graduates on Thursday...
RWJBarnabas Executive Receives 2024 EJI Excellence in Medicine Award
New Jersey Business Magazine· 12 hours agoAndy Anderson, MD was recognized with the 2024 Edward J. Ill, M.D., Excellence in Medicine Awards’...
Opinion | Reflecting on Two Decades in Medicine: Advice to New Graduates
MedPage Today· 2 days agoBetween the 2022-2023 and the 2023-2024 academic years, the number of college graduates applying to...
JPMorgan Chase & Co. Lowers Prime Medicine (NYSE:PRME) Price Target to $15.00
ETF DAILY NEWS· 1 day agoPrime Medicine (NYSE:PRME – Free Report) had its target price cut by JPMorgan Chase & Co. from $16.00 to $15.00 in a research note released on Monday, Benzinga reports. They ...
EU regulator scraps approval for pregnancy drug over cancer risk
WHTC 1450 Holland· 7 hours ago(Reuters) - The European Medicines Agency (EMA) on Friday recommended scrapping approval for a drug...
Blueprint Medicines Co. (NASDAQ:BPMC) Forecasted to Post Q2 2024 Earnings of ($1.40) Per Share
ETF DAILY NEWS· 1 day agoBlueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Analysts at Zacks Research issued their Q2 2024 earnings per share estimates for shares of Blueprint Medicines ...